Our Pricing

Semaglutide Injections UK - Lowest competitive pricing

Published on: June 03, 2026

Searching for semaglutide injections uk lowest price options with genuine UK-licensed medication? At Cured Pharmacy, Wegovy semaglutide is available from £79.00 with transparent upfront pricing, a free clinical assessment by UK prescribers, and 100% discreet packaging. Our GPhC-registered pharmacy guarantees authentic medicines dispensed under the supervision of Superintendent Pharmacist Tarun Kumar (GPhC 2233073).

How Semaglutide Injections Work for Weight Loss

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed by the MHRA for chronic weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with weight-related comorbidities [1]. It mimics the action of natural GLP-1 hormones, slowing gastric emptying, reducing appetite, and enhancing feelings of fullness after meals.

In the landmark STEP 1 trial, participants receiving once-weekly semaglutide 2.4mg achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [1]. These results demonstrate semaglutide's efficacy when combined with a reduced-calorie diet and increased physical activity, as recommended by NICE guidelines.

Wegovy Semaglutide Dosing Schedule and Administration

Wegovy follows a carefully designed dose escalation schedule to minimise gastrointestinal side effects whilst optimising weight loss outcomes [2]. Treatment begins with 0.25mg once weekly for four weeks, gradually increasing every four weeks through 0.5mg, 1mg, and 1.7mg doses, before reaching the maintenance dose of 2.4mg weekly.

Each pre-filled pen is administered subcutaneously into the abdomen, thigh, or upper arm. Our UK prescribers provide detailed injection technique guidance during your clinical assessment, ensuring you feel confident with self-administration. The once-weekly dosing schedule offers significant convenience compared to daily injectable alternatives.

Starting Your Semaglutide Treatment Safely

Your UK-registered prescriber will review your complete medical history, current medications, and weight loss goals before determining suitability for semaglutide injections. Certain conditions, including personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, contraindicate semaglutide use [2]. Subject to prescriber approval, treatment can commence with your starter dose delivered discreetly to your UK address.

Semaglutide Injections UK: Expected Results and Clinical Evidence

Clinical trial data demonstrates that semaglutide produces sustained weight loss when used as part of a comprehensive lifestyle intervention programme [1]. In STEP 2, participants with type 2 diabetes achieved an average 9.6% body weight reduction with semaglutide 2.4mg, compared to 3.4% with semaglutide 1mg and 3.4% with placebo over 68 weeks [3].

Individual results vary based on adherence to treatment, dietary modifications, and physical activity levels. Most patients begin noticing appetite suppression within the first few weeks, with progressive weight loss becoming evident as doses increase. Your UK prescriber will schedule follow-up assessments to monitor progress, adjust treatment if necessary, and provide ongoing support throughout your weight management journey.

Long-Term Weight Maintenance with Semaglutide

The STEP 4 trial examined weight maintenance after initial weight loss, finding that participants who continued semaglutide maintained an average 17.4% total body weight reduction from baseline, whilst those switched to placebo regained 6.9% [4]. This evidence supports semaglutide's role in long-term weight management, subject to continued treatment and lifestyle modifications as recommended by your prescriber.

Common Side Effects and How to Manage Them

Gastrointestinal side effects are the most frequently reported adverse events with semaglutide, particularly during dose escalation [2]. Nausea, vomiting, diarrhoea, and constipation typically diminish as your body adjusts to each new dose level. Eating smaller, more frequent meals and avoiding high-fat foods can help minimise these symptoms.

Serious but rare side effects include pancreatitis, gallbladder problems, and hypoglycaemia (particularly in patients taking other glucose-lowering medications). Contact your prescriber immediately if you experience severe abdominal pain, persistent vomiting, or signs of an allergic reaction. Our clinical team at Cured Pharmacy remains available on (+44) 116 4646009 to address any concerns during your treatment.

Why Choose Cured Pharmacy for Semaglutide Injections UK

At Cured Pharmacy (GPhC Registration 9012511), we guarantee the lowest prices on genuine UK-licensed semaglutide injections, with Wegovy available from £79.00. Our transparent pricing model shows exact costs before you complete your free online consultation, eliminating hidden fees or unexpected charges at checkout.

Every prescription is reviewed by our UK-registered clinical team, ensuring safe, appropriate treatment tailored to your individual health profile. We dispense only authentic medications sourced through licensed UK wholesalers, never grey-market imports. Your treatment arrives in 100% discreet packaging, with no external markings indicating contents, protecting your privacy throughout the process.

Our Clinical Assessment Process

The online consultation takes under three minutes to complete and covers your medical history, current medications, weight loss goals, and any contraindications. A UK prescriber reviews your assessment within hours, approving treatment or requesting additional information if needed. Once approved, your prescription is dispensed by our GPhC-registered pharmacy and dispatched for next-day delivery across the UK, subject to stock availability and courier schedules.

Comparing Semaglutide to Other Weight Loss Treatments

Semaglutide represents one of several GLP-1 receptor agonists licensed for weight management in the UK, each with distinct characteristics and clinical profiles. Liraglutide, marketed as Saxenda, requires daily injections and demonstrated an average 8% body weight reduction in the SCALE trial [5], whilst semaglutide's once-weekly administration and superior efficacy make it a preferred option for many patients.

Newer dual GIP/GLP-1 receptor agonists have shown even greater weight loss in clinical trials, though individual response varies significantly. Your UK prescriber will discuss all licensed options during your consultation, recommending the most appropriate treatment based on your medical history, lifestyle preferences, and weight management goals. All prescription weight loss medications require ongoing commitment to dietary changes and increased physical activity for optimal results.

Injectable vs Oral Weight Loss Medications

Injectable GLP-1 receptor agonists like semaglutide typically produce greater weight loss than oral alternatives such as orlistat or naltrexone/bupropion combinations [6]. Whilst oral medications may suit patients uncomfortable with self-injection, the superior efficacy and convenient once-weekly dosing of semaglutide make it the first-line choice for many seeking significant, sustained weight reduction under medical supervision.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Electronic Medicines Compendium. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Medicines.org.uk. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
3. Davies, M., Færch, L., Jeppesen, O. K., et al. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971–984. https://doi.org/10.1016/S0140-6736(21)00213-0 [accessed 13 August 2026]
4. Rubino, D., Abrahamsson, N., Davies, M., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
5. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
6. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity. Technology appraisal guidance [TA875]. NICE. https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Semaglutide is a prescription-only medicine licensed for chronic weight management in adults with a BMI ≥30 kg/m² or ≥27 kg/m² with weight-related comorbidities, used alongside a reduced-calorie diet and increased physical activity.